# AbbVie Inc.: Form DEF 14A, filed Mar 18, 2024

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: DEF 14A
- Filed: 2024-03-18
- Accepted by EDGAR: Mar 18, 2024, 16:15 ET
- Period: 2024-05-03
- Accession: 0001558370-24-003496
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/abbv-20240503xdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000155837024003496/abbv-20240503xdef14a.htm

Filed Mar 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001558370-24-003496. Last ingested by Listed: Nov 13, 2026, 16:34 ET. No prices; not investment advice.
